State of the Medtech, Diagnostics & Digital Health landscape in Q3 2025
The quarter saw a big increase in venture financing as opposed to last year’s Q3. Most of this increase went towards later-stage companies, but investor appetite for seed-stage remained. In vitro and digital health were most popular, with some more niche sectors experiencing renewed activit
